SC
CRBU icon

Steven Cohen’s Caribou Biosciences CRBU Stock Holding History

Steven Cohen’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,000
Closed -$196K – 2133
2024
Q3 		$196K Buy
+100,000
New +$205K ﹤0.01% 1796

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Steven Cohen's CRBU Position: Q2 2026 in Review

Steven Cohen reduced its Caribou Biosciences (CRBU) stake by 92% in Q2 2026, selling an estimated $340K and leaving 15,769 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3850.

Steven Cohen first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $20.2M in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Steven Cohen held 15,769 shares of Caribou Biosciences worth $27.8K as of Q2 2026.
  • Steven Cohen sold 171,853 Caribou Biosciences shares in Q2 2026, an estimated $340K.
  • Caribou Biosciences made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3850 holding.
  • Steven Cohen first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Steven Cohen's Caribou Biosciences position peaked at $20.2M in Q4 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.